Investors' belief in Societal CDMO's lackluster revenue performance not improving may be causing its low P/S ratio. The company's inferior revenue outlook compared to the industry average contributes to this. A significant change in fortune is needed to justify a higher P/S.
The company's high debt and lack of profitability strain its balance sheet. Negative free cash flow adds risk, but its US$417.4m market cap could potentially allow capital raising to strengthen the balance sheet.
Investors' belief in Avid Bioservices' stagnant revenue performance and future growth lagging behind the industry has led to its low P/S. The underwhelming revenue outlook and shareholders' pessimism impact the P/S negatively.
Despite good revenue growth, the market expected more, as seen in the share price drop. This could hint at delayed revenue growth. The recent sell-off might be an investment chance considering the signs of a continued growth trend.
71750344 :
Is NIO still a buy? There has been so much dissing of NIO, I can’t figure out why. I own several shares of NIO and watched my successful choice and investment really dwindle in value.
アビッド・バイオサービシズに関するコメント
Most anticipated earnings and economic releases for the coming week, June 19th 23’
...
$ヘルスケア・セレクト・セクター SPDR ファンド(XLV.US)$$カタリスト・ファーマシューティカルズ(CPRX.US)$$アビッド・バイオサービシズ(CDMO.US)$$アニクサ・バイオサイエンシズ(ANIX.US)$$ブルーバード・バイオ(BLUE.US)$
Current top watch ⚡️⚡️
コラムToday's Pre-Market Stock Movers: NIO, PATH, COUP, RKLB and More
In reaction to earnings/guidance:
• $Coupa Software(COUP.US)$ +12% (also authorizes new $100mln share repurchase program),$REVグループ(REVG.US)$ -5%,$G-IIIアパレル・グループ(GIII.US)$ + 2.1%,$ギットラブ(GTLB.US)$ +1.2%
Other news:
• $タッパーウェア・ブランズ(TUP.US)$ +6.7% (recovers a bit after falling -33% during regular session)
• $Avaya Holdings(AVYA.US)$ +6.6% (authorizes workforce reduction plan)
• $バセット・ファニチャー・インダストリーズ(BSET.US)$ +5% (acqu...
まだコメントはありません